Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment-Reference-Cited by-同舟云学术

Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment

Published:2012-02 Issue:2 Volume:12 Page:465-470
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Castro Sandra B.R.,Junior Celso O.R.,Alves Caio C.S.,Dias Alyria T.,Alves Lívia L.,Mazzoccoli Luciano,Mesquita Felipe P.,Figueiredo Nathália S.V.,Juliano Maria A.,Castañon Maria Christina M.N.,Gameiro Jacy,Almeida Mauro V.,Teixeira Henrique C.,Ferreira Ana Paula

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference47 articles.

1. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis;Ishizu;Brain,2005

2. Multiple sclerosis: a two stage disease;Steinman;Nat Immunol,2001

3. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis;Hedegaard;Immunology,2008